Client Result
Orrick Advises Catalyst Biosciences in Reverse Merger with GNI Group
1 minute read | December.28.2022

1 minute read | December.28.2022
1 minute read | December.20.2022
1 minute read | November.03.2022
May.24.2022
May.24.2022
Orrick advised South San Francisco-based biopharmaceutical company Catalyst Biosciences, Inc.
April.13.2022
September.10.2021
June.04.2020